Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease (Q36526863)

14 August 2017

1 reference

title

Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease (English)

1 reference

14 August 2017

0 references

0 references

A. M. Sawyerr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681952

28 October 2022

A. J. Wakefield

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681952

28 October 2022

M. Hudson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681952

28 October 2022

A. P. Dhillon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681952

28 October 2022

R. E. Pounder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681952

28 October 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1991.tb00001.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1991.tb00001.x/fullpdf

28 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Alimentary Pharmacology & Therapeutics

28 October 2022

published in

1 reference

14 August 2017

5

1 reference

14 August 2017

1

1 reference

14 August 2017

1-14

1 reference

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction

14 August 2017

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT.

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

THE MIGRATION OF LYMPHOCYTES THROUGH THE ENDOTHELIUM OF VENULES IN LYMPH NODES: AN ELECTRON MICROSCOPE STUDY.

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Adhesion molecules controlling lymphocyte migration

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

A possible route for lymphocyte migration into diseased tissues

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Functional and morphological changes in post-capillary venules in relation to lymphocytic infiltration into BCG-induced granulomata in rat skin

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Binding of normal human mononuclear cells to blood vessels in rheumatoid arthritis synovial membrane

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Integrins: a family of cell surface receptors

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

New perspectives in cell adhesion: RGD and integrins

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Leucocyte adhesion to cells. Molecular basis, physiological relevance, and abnormalities

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Functional evidence that intercellular adhesion molecule-1 (icam-1) is a ligand for lfa-1d-ependent adhesion in t cell-mediated cytotoxicity

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Identification of an inducible endothelial-leukocyte adhesion molecule

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Regulation of intercellular adhesion molecule-1 expression on endothelial cells with correlation to lymphocyte-endothelial binding

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

28 October 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Migration of lymphocytes through endothelial cell monolayers: augmentation by interferon-gamma

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts

28 October 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

28 October 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

28 October 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

28 October 2022

Macrophage procoagulants

49

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Delayed Hypersensitivity in Man: Effects of Systemic Anticoagulation

28 October 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity

28 October 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide

28 October 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigration

28 October 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

IL-1 stimulates IL-6 production in endothelial cells.

28 October 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Cytokine regulation of interleukin 6 production by human endothelial cells

28 October 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor

28 October 2022

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils

28 October 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis

28 October 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

28 October 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

28 October 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

28 October 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells

28 October 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins

28 October 2022

73

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes

28 October 2022

74

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Leukotriene B4 increases the lymphocyte binding to endothelial cells

28 October 2022

76

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Prostaglandins modulate macrophage Ia expression

28 October 2022

77

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Eicosanoids are regulatory molecules in gamma-interferon-induced endothelial antigenicity and adherence for leucocytes

28 October 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection

28 October 2022

79

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

PGE1 inhibits neutrophil adherence and neutrophil-mediated injury to cultured endothelial cells

28 October 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Prostaglandins as endogenous mediators of interleukin 1 production

28 October 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Reduction by dexamethasone of chemotactic activity in inflammatory exudates

28 October 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

An experiment to determine the active therapeutic moiety of sulphasalazine

28 October 2022

86

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa

28 October 2022

87

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Mechanism of action of 5-aminosalicylic acid and its derivatives

28 October 2022

90

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa

28 October 2022

91

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils

28 October 2022

93

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.

28 October 2022

94

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

28 October 2022

95

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid

28 October 2022

96

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment

28 October 2022

97

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease

28 October 2022

98

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes

28 October 2022

99

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Inhibition of antibody secretion by 5-aminosalicylic acid.

28 October 2022

100

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

28 October 2022

102

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Therapeutic potential of fish oil in the treatment of ulcerative colitis

28 October 2022

103

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Cyclosporin for Crohn's disease.

28 October 2022

105

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

28 October 2022

106

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Cyclosporin A treatment in inflammatory bowel disease

28 October 2022

107

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

28 October 2022

Cyclosporine

108

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity

28 October 2022

109

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

28 October 2022

111

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

28 October 2022

112

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

28 October 2022

114

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Sparing of suppressor cells: a critical action of cyclosporine

28 October 2022

115

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Phagocytic Cell Function in Response to Immunosuppressive Therapy

28 October 2022

116

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Coagulation and the expression of cell-mediated immunity

28 October 2022

118

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Cyclosporine as a biologic response modifier in the regulation of monocyte and endothelial cell procoagulant synthesis

28 October 2022

119

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

28 October 2022

121

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1991.TB00001.X

28 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1681952

28 October 2022

1 reference